Perceptive Advisors as of Dec. 31, 2022
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 95 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 9.5 | $338M | 28M | 12.21 | |
| Madrigal Pharmaceuticals (MDGL) | 8.4 | $300M | 1.0M | 290.25 | |
| Amylyx Pharmaceuticals (AMLX) | 6.3 | $225M | 6.1M | 36.95 | |
| Cerevel Therapeutics Hldng I (CERE) | 5.8 | $205M | 6.5M | 31.54 | |
| Prometheus Biosciences | 3.7 | $133M | 1.2M | 110.00 | |
| Verona Pharma Sponsored Ads (VRNA) | 3.6 | $128M | 4.9M | 26.13 | |
| Horizon Therapeutics Pub L SHS | 3.1 | $109M | 960k | 113.80 | |
| Mirati Therapeutics | 2.8 | $99M | 2.2M | 45.31 | |
| Lianbio Sponsored Ads (LIANY) | 2.7 | $94M | 58M | 1.64 | |
| Sarepta Therapeutics (SRPT) | 2.4 | $84M | 649k | 129.58 | |
| Inhibrx (INBX) | 2.3 | $82M | 3.3M | 24.64 | |
| Arcellx Common Stock (ACLX) | 2.3 | $81M | 2.6M | 30.98 | |
| Aldeyra Therapeutics (ALDX) | 2.2 | $79M | 11M | 6.96 | |
| Xenon Pharmaceuticals (XENE) | 2.1 | $76M | 1.9M | 39.43 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.1 | $74M | 4.0M | 18.30 | |
| Bellus Health Com New | 2.1 | $73M | 8.9M | 8.22 | |
| Springworks Therapeutics (SWTX) | 1.9 | $68M | 2.6M | 26.01 | |
| Nuvalent Inc-a (NUVL) | 1.9 | $67M | 2.3M | 29.78 | |
| Iovance Biotherapeutics (IOVA) | 1.8 | $64M | 10M | 6.39 | |
| Vaxcyte (PCVX) | 1.6 | $56M | 1.2M | 47.95 | |
| BioMarin Pharmaceutical (BMRN) | 1.5 | $52M | 507k | 103.49 | |
| Adma Biologics (ADMA) | 1.3 | $46M | 12M | 3.88 | |
| Meiragtx Holdings (MGTX) | 1.3 | $45M | 7.0M | 6.52 | |
| Treace Med Concepts (TMCI) | 1.3 | $45M | 1.9M | 22.99 | |
| Female Health (VERU) | 1.2 | $42M | 7.9M | 5.28 | |
| Albireo Pharma | 1.1 | $38M | 1.8M | 21.61 | |
| Cogent Biosciences (COGT) | 1.0 | $37M | 3.2M | 11.56 | |
| Miragen Therapeutics (VRDN) | 1.0 | $36M | 1.2M | 29.21 | |
| Rapt Therapeutics (RAPT) | 1.0 | $36M | 1.8M | 19.80 | |
| Zymeworks Del (ZYME) | 1.0 | $36M | 4.5M | 7.86 | |
| Acrivon Therapeutics Common Stock (ACRV) | 1.0 | $35M | 3.0M | 11.52 | |
| Establishment Labs Holdings Ord (ESTA) | 0.9 | $33M | 498k | 65.65 | |
| Astria Therapeutics (ATXS) | 0.9 | $33M | 2.2M | 14.89 | |
| Cincor Pharma | 0.9 | $32M | 2.6M | 12.29 | |
| Immatics SHS (IMTX) | 0.9 | $30M | 3.5M | 8.71 | |
| Relay Therapeutics (RLAY) | 0.8 | $29M | 1.9M | 14.94 | |
| Lyra Therapeutics (LYRA) | 0.8 | $29M | 9.1M | 3.14 | |
| Outset Med (OM) | 0.8 | $28M | 1.1M | 25.82 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.6 | $23M | 412k | 55.10 | |
| Rocket Pharmaceuticals (RCKT) | 0.6 | $21M | 1.1M | 19.57 | |
| Vbi Vaccines Inc Cda Com New | 0.6 | $20M | 52M | 0.39 | |
| Rain Therapeutics | 0.6 | $20M | 2.5M | 8.00 | |
| Akero Therapeutics (AKRO) | 0.5 | $19M | 351k | 54.80 | |
| Tarsus Pharmaceuticals (TARS) | 0.5 | $19M | 1.3M | 14.66 | |
| Solid Biosciences Com New (SLDB) | 0.5 | $19M | 3.5M | 5.38 | |
| Nautilus Biotechnology (NAUT) | 0.5 | $16M | 9.1M | 1.80 | |
| Roivant Sciences SHS (ROIV) | 0.4 | $16M | 2.0M | 7.99 | |
| Athira Pharma (ATHA) | 0.4 | $15M | 4.8M | 3.17 | |
| Prothena Corp SHS (PRTA) | 0.4 | $14M | 238k | 60.25 | |
| Verrica Pharmaceuticals (VRCA) | 0.4 | $14M | 5.0M | 2.75 | |
| Axogen (AXGN) | 0.4 | $14M | 1.4M | 9.98 | |
| Revance Therapeutics (RVNC) | 0.4 | $14M | 729k | 18.46 | |
| Cytek Biosciences (CTKB) | 0.4 | $13M | 1.3M | 10.21 | |
| CryoLife (AORT) | 0.4 | $13M | 1.1M | 12.12 | |
| Bridgebio Pharma (BBIO) | 0.4 | $13M | 1.7M | 7.62 | |
| Iveric Bio | 0.4 | $13M | 587k | 21.41 | |
| Neurocrine Biosciences (NBIX) | 0.3 | $12M | 100k | 119.44 | |
| Larimar Therapeutics (LRMR) | 0.3 | $12M | 2.9M | 4.13 | |
| Caremax Com Cl A | 0.3 | $11M | 3.1M | 3.65 | |
| Intuitive Surgical Com New (ISRG) | 0.3 | $11M | 40k | 265.35 | |
| Morphic Hldg (MORF) | 0.3 | $9.7M | 363k | 26.75 | |
| Dice Therapeutics | 0.3 | $9.2M | 293k | 31.20 | |
| Landos Biopharma | 0.2 | $7.4M | 15M | 0.50 | |
| Scpharmaceuticals (SCPH) | 0.2 | $6.8M | 952k | 7.17 | |
| Hillevax (HLVX) | 0.2 | $6.8M | 406k | 16.73 | |
| Singular Genomics Systems In (OMIC) | 0.2 | $6.6M | 3.3M | 2.01 | |
| Isoplexis Corp | 0.2 | $6.3M | 4.1M | 1.55 | |
| Penumbra (PEN) | 0.2 | $5.7M | 25k | 222.46 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $5.4M | 341k | 15.75 | |
| Natera (NTRA) | 0.1 | $5.2M | 130k | 40.17 | |
| Cymabay Therapeutics | 0.1 | $4.4M | 709k | 6.27 | |
| Cassava Sciences Put Option (SAVA) | 0.1 | $4.4M | 150k | 29.54 | |
| Envveno Medical (NVNO) | 0.1 | $4.0M | 782k | 5.10 | |
| Nanobiotix Sponsored Ads (NBTX) | 0.1 | $3.9M | 1.1M | 3.67 | |
| Somalogic Class A Com | 0.1 | $3.8M | 1.5M | 2.51 | |
| Tyra Biosciences (TYRA) | 0.1 | $3.8M | 494k | 7.60 | |
| Point Biopharma Global | 0.1 | $3.6M | 500k | 7.29 | |
| Leap Therapeutics | 0.1 | $3.0M | 6.7M | 0.45 | |
| Cabaletta Bio (CABA) | 0.1 | $2.9M | 318k | 9.25 | |
| Kronos Bio (KRON) | 0.1 | $2.8M | 1.8M | 1.62 | |
| Procept Biorobotics Corp (PRCT) | 0.1 | $2.7M | 65k | 41.54 | |
| Immunovant (IMVT) | 0.1 | $2.7M | 150k | 17.75 | |
| Athenex | 0.1 | $2.3M | 16M | 0.15 | |
| Privia Health Group (PRVA) | 0.1 | $2.0M | 90k | 22.71 | |
| Travere Therapeutics (TVTX) | 0.1 | $1.9M | 91k | 21.03 | |
| Acumen Pharmaceuticals (ABOS) | 0.1 | $1.9M | 348k | 5.40 | |
| Dariohealth Corp Com New (DRIO) | 0.0 | $1.4M | 328k | 4.28 | |
| Clover Health Investments Com Cl A (CLOV) | 0.0 | $1.4M | 1.5M | 0.93 | |
| Nevro (NVRO) | 0.0 | $1.2M | 30k | 39.60 | |
| Pear Therapeutics Class A Com (PEARQ) | 0.0 | $1.1M | 901k | 1.18 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $777k | 290k | 2.68 | |
| Motus Gi Hldgs Com New | 0.0 | $76k | 90k | 0.84 | |
| Eqrx *w Exp 12/17/202 | 0.0 | $67k | 250k | 0.27 | |
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $31k | 60k | 0.52 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $9.2k | 167k | 0.06 |
